Treatment of Good Prognosis, BCL-6 Negative Diffuse Large Cell Lymphoma With CHOP-R in Patients < 61 Years Old.

Radiotherapy in Primary Mediastinal Lymphoma

NCT01230008 ·Status: COMPLETED

Retrospective Analysis of Rituximab-containing Immunochemotherapy for Burkitt's or Burkitt-like Lymphoma in Adults

NCT01809600 ·Status: COMPLETED

Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma

NCT01856192 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Diffuse Large B Cell Lymphoma of the Adult: Randomization Between High Dose Chemotherapy With Rituximab and CHOP 14-Rituximab

NCT00561379 ·Status: COMPLETED ·Phase: NA

Mini-CHOP and Rituximab in Patients Aged Over 80 Years

NCT01087424 ·Status: COMPLETED ·Phase: PHASE2

RLC Followed by CR-CHOP in Elderly Patients with Newly-diagnosed DEL

NCT06674096 ·Status: RECRUITING ·Phase: PHASE2

A Study Comparing the Efficacy and Safety Between H-CHOP and R-CHOP in Untreated CD20-Positive Diffuse Large B-cell Lymphoma Patients

NCT05040906 ·Status: UNKNOWN ·Phase: PHASE3

The Safety and Effectiveness of 4R-CHOP+4R vs 6R-CHOP+2R in Newly Diagnosed Patients With DLBCL in Low Risk

NCT05018520 ·Status: RECRUITING ·Phase: PHASE3

Revlimid Dose 25 mg in Association With (R-CHOP) in the Treatment Follicular Lymphoma

NCT01393756 ·Status: COMPLETED ·Phase: PHASE2

Comparison of High-Dose Chemotherapy + Rituximab and CHOP + Rituximab in High-Risk Follicular Lymphoma

NCT00435955 ·Status: UNKNOWN ·Phase: PHASE3

TREatment of degeNerative and Neoplastic Diseases With Rituximab

NCT01277172 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Ibrutinib Combined With R-CHOP/R-DHAP in Newly Diagnosed Mantle Cell Lymphoma Patients Who Aged ≤65 Years

NCT05429918 ·Status: UNKNOWN

Comparison of HD Chemotherapy Followed by Auto-transplant and R-CHOP in High Risk Patients With DLBCL.

NCT00355199 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of R-CMOP Versus R-CHOP in the Initial Treatment of DLBCL

NCT06760039 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma

NCT00290667 ·Status: COMPLETED ·Phase: PHASE2

R-CHOP Combined With Lenalidomide in the First-line Treatment for Patients With Diffuse Large B Cell Lymphoma

NCT04214626 ·Status: COMPLETED ·Phase: PHASE2

R-CHOP + R-HAD vs R-CHOP Followed by Maintenance Lenalidomide + Rituximab vs Rituximab for Older Patients With MCL

NCT01865110 ·Status: COMPLETED ·Phase: PHASE3

Orelabrutinib, Rituximab and Combination Chemotherapy in Newly-diagnosed Aggressive B-cell Non-Hodgkin Lymphoma

NCT05097443 ·Status: UNKNOWN ·Phase: PHASE3

Prognosis Of Patients With Aggressive B-Cell Lymphoma, Treated With Rituximab+Anthracycline Regimen

NCT01478269 ·Status: COMPLETED

An Observational Study of MabThera/Rituxan (Rituximab) Plus Chemotherapy As First-Line Treatment in Patients With Diffuse Large B-Cell Lymphoma or Follicular Lymphoma

NCT01340443 ·Status: COMPLETED

Mega-CHOEP: Conventional Chemo Vs HD Chemo Followed by Auto SCT in Younger Pts With Aggressive Non-Hodgkin's Lymphoma

NCT00129090 ·Status: COMPLETED ·Phase: PHASE3

Lenalidomide and R-CHOP in B-cell Lymphoma

NCT00901615 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

An Observational Study of MabThera/Rituxan (Rituximab) in Combination With CHOP Chemotherapy in First-Line in Patients With Diffuse Large B-Cell Lymphoma

NCT01724294 ·Status: TERMINATED

A Study Comparing the Efficacy and Safety of G-CHOP Versus R-CHOP in Untreated Diffuse Large B-cell Lymphoma Patients

NCT03650933 ·Status: RECRUITING ·Phase: PHASE3

Lenalidomide Combined With R-CHOP(R2-CHOP) in Newly Diagnosed Double-expressor Diffuse Large B-Cell Lymphoma Patients

NCT04164368 ·Status: COMPLETED ·Phase: PHASE2